See more : MPX International Corporation (MPXI.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Origin Agritech Limited (SEED) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Origin Agritech Limited, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Protector Forsikring ASA (PSKRF) Income Statement Analysis – Financial Results
- Navient Corporation (NAVI) Income Statement Analysis – Financial Results
- Hemisphere Energy Corporation (HME.V) Income Statement Analysis – Financial Results
- Elbit Imaging Ltd. (EMITF-M.TA) Income Statement Analysis – Financial Results
- Kinarus Therapeutics Holding AG (PRFN.SW) Income Statement Analysis – Financial Results
Origin Agritech Limited (SEED)
About Origin Agritech Limited
Origin Agritech Limited, together with its subsidiaries, operates an agricultural biotechnology and an e-commerce platform in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as develops hybrid seed technology. The company also operates an e-commerce platform, which provides range of products, including agricultural seed products that comprise corn, rice, and vegetable seeds; other agricultural inputs, such as fertilizers and agricultural chemicals; foods; household products; and other consumer products to farmers through online and mobile ordering. It has a collaboration agreement with Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 93.31M | 52.58M | 46.43M | 52.51M | 92.44M | 12.93M | 0.00 | 335.25M | 376.25M | 414.89M | 481.69M | 552.11M | 567.43M | 584.86M | 592.49M | 513.49M | 489.38M | 207.38M | 0.00 | 0.00 | 98.72M | 75.06M |
Cost of Revenue | 76.06M | 36.39M | 33.61M | 49.00M | 105.27M | 7.05M | 0.00 | 259.25M | 264.04M | 301.15M | 315.08M | 387.78M | 371.59M | 353.59M | 392.84M | 404.80M | 462.85M | 129.22M | 0.00 | 0.00 | 46.01M | 50.34M |
Gross Profit | 17.25M | 16.19M | 12.81M | 3.51M | -12.83M | 5.88M | 0.00 | 76.00M | 112.21M | 113.74M | 166.61M | 164.33M | 195.84M | 231.27M | 199.65M | 108.70M | 26.53M | 78.17M | 0.00 | 0.00 | 52.71M | 24.72M |
Gross Profit Ratio | 18.48% | 30.80% | 27.60% | 6.69% | -13.88% | 45.49% | 0.00% | 22.67% | 29.82% | 27.42% | 34.59% | 29.76% | 34.51% | 39.54% | 33.70% | 21.17% | 5.42% | 37.69% | 0.00% | 0.00% | 53.40% | 32.93% |
Research & Development | 7.45M | 7.43M | 1.98M | 4.12M | 13.27M | 27.13M | 38.68M | 44.03M | 48.74M | 40.38M | 42.16M | 37.63M | 44.77M | 38.36M | 33.47M | 24.51M | 28.44M | 6.98M | 0.00 | 0.00 | 5.37M | 2.50M |
General & Administrative | 14.23M | 14.32M | 73.32M | 58.07M | 27.23M | 32.15M | 34.91M | 62.16M | 40.68M | 46.43M | 66.15M | 77.59M | 86.75M | 78.71M | 64.83M | 73.36M | 92.25M | 28.98M | 0.00 | 0.00 | 9.64M | 0.00 |
Selling & Marketing | 8.36M | 7.34M | 5.56M | 4.82M | 4.04M | 411.00K | 0.00 | 38.08M | 39.99M | 58.97M | 55.38M | 56.44M | 56.83M | 52.23M | 55.65M | 53.20M | 57.99M | -27.04M | 0.00 | 0.00 | 6.48M | 8.90M |
SG&A | 22.59M | 21.66M | 78.88M | 62.89M | 31.27M | 32.56M | 34.91M | 100.24M | 80.67M | 105.40M | 121.53M | 134.02M | 143.58M | 130.94M | 120.48M | 126.56M | 150.24M | 56.04M | 6.91M | 4.43K | 16.12M | 8.90M |
Other Expenses | 2.20M | 26.34M | 25.53M | 956.00K | -1.03M | -18.29M | -5.03M | -6.96M | -18.54M | -7.56M | -15.24M | -3.85M | -5.12M | 0.00 | 0.00 | 0.00 | 0.00 | -2.31M | 0.00 | 0.00 | 0.00 | 8.74M |
Operating Expenses | 32.24M | 29.09M | 80.86M | 67.01M | 43.51M | 41.40M | 68.56M | 137.31M | 110.87M | 138.22M | 148.45M | 167.80M | 183.23M | 169.29M | 153.95M | 151.07M | 178.68M | 60.71M | 6.91M | 4.43K | 21.49M | 20.14M |
Cost & Expenses | 108.30M | 65.48M | 114.47M | 116.01M | 148.78M | 48.45M | 68.56M | 396.56M | 374.91M | 439.37M | 463.53M | 555.58M | 554.82M | 522.88M | 546.80M | 555.87M | 641.53M | 189.93M | 6.91M | 4.43K | 67.50M | 70.48M |
Interest Income | 0.00 | 8.23M | 8.56M | 5.80M | 3.00K | 6.00K | 1.43M | 162.00K | 775.00K | 596.00K | 1.78M | 2.55M | 1.77M | 1.63M | 2.04M | 5.20M | 10.94M | 888.09K | 1.38M | 1.38M | 440.00K | 134.00K |
Interest Expense | 982.00K | 8.23M | 8.56M | 5.80M | 4.68M | 22.79M | 9.01M | 14.25M | 18.63M | 19.74M | 11.33M | 4.03M | 1.47M | 8.54M | 16.78M | 36.94M | 21.70M | 1.83M | 1.83M | 0.00 | 417.00K | 172.00K |
Depreciation & Amortization | 4.03M | 3.90M | 8.28M | 10.61M | 13.80M | 16.45M | 27.69M | 31.22M | 30.55M | 28.52M | 28.16M | 19.54M | 23.31M | 21.71M | 21.27M | 22.30M | 22.03M | 6.76M | 0.00 | 0.00 | -166.00K | -6.58M |
EBITDA | 67.84M | 17.35M | -137.91M | -86.01M | -46.67M | -19.06M | -85.15M | -34.21M | -19.75M | -256.00K | 40.33M | 22.65M | 25.73M | 105.92M | 73.67M | 13.68M | -119.85M | 21.60M | -6.91M | 77.13M | 38.39M | 31.05M |
EBITDA Ratio | 72.71% | 32.99% | -73.75% | -98.88% | -46.02% | -147.45% | 0.00% | -8.93% | 8.68% | 0.93% | 11.06% | 4.10% | 6.93% | 16.11% | 12.43% | -1.40% | -24.49% | 10.42% | 0.00% | 0.00% | 31.45% | -2.68% |
Operating Income | -14.99M | 13.45M | -68.04M | -63.49M | -56.34M | -35.52M | -68.56M | -61.31M | 1.34M | -24.48M | 18.16M | -3.47M | 12.61M | 61.98M | 45.70M | -42.38M | -152.15M | 17.45M | -6.91M | -4.43K | 31.22M | 4.58M |
Operating Income Ratio | -16.07% | 25.57% | -146.57% | -120.91% | -60.94% | -274.77% | 0.00% | -18.29% | 0.36% | -5.90% | 3.77% | -0.63% | 2.22% | 10.60% | 7.71% | -8.25% | -31.09% | 8.42% | 0.00% | 0.00% | 31.62% | 6.10% |
Total Other Income/Expenses | 77.82M | 15.21M | 11.01M | -10.83M | -3.65M | -111.68M | -52.29M | -7.54M | -9.91M | -24.04M | -4.39M | 2.55M | -11.66M | 11.35M | -55.89M | -3.18M | 2.49M | 234.13K | 234.13K | 1.61M | -4.49M | -583.00K |
Income Before Tax | 62.83M | 2.31M | -126.90M | -102.42M | -65.14M | -152.79M | -76.14M | -75.40M | -16.52M | -48.52M | 13.77M | -923.00K | 949.00K | 75.67M | -10.19M | -45.56M | -149.67M | 17.69M | 0.00 | 0.00 | 30.63M | 11.12M |
Income Before Tax Ratio | 67.34% | 4.40% | -273.35% | -195.03% | -70.47% | -1,181.94% | 0.00% | -22.49% | -4.39% | -11.70% | 2.86% | -0.17% | 0.17% | 12.94% | -1.72% | -8.87% | -30.58% | 8.53% | 0.00% | 0.00% | 31.03% | 14.82% |
Income Tax Expense | 162.00K | -14.00K | 178.00K | 425.00K | 510.00K | -94.48M | -46.02M | 1.44M | 1.30M | -38.38M | 4.46M | 1.86M | 13.73M | 9.32M | 11.73M | -4.00M | -49.00K | 1.40M | 5.53M | 4.43K | 1.50M | 3.23M |
Net Income | 55.33M | 2.33M | -127.08M | -102.84M | -65.65M | -153.66M | -75.67M | -65.58M | -13.81M | -9.53M | 7.49M | -1.43M | -23.08M | 49.05M | -40.82M | -43.29M | -163.20M | 16.42M | -5.53M | -4.43K | 26.56M | 8.12M |
Net Income Ratio | 59.30% | 4.42% | -273.73% | -195.84% | -71.02% | -1,188.70% | 0.00% | -19.56% | -3.67% | -2.30% | 1.56% | -0.26% | -4.07% | 8.39% | -6.89% | -8.43% | -33.35% | 7.92% | 0.00% | 0.00% | 26.91% | 10.81% |
EPS | 8.43 | 0.41 | -22.62 | -20.45 | -15.69 | -50.18 | -26.95 | -28.69 | -6.06 | -4.19 | 3.20 | -0.61 | -10.00 | 21.20 | -17.74 | -18.83 | -70.14 | 15.21 | -5.53 | 0.00 | 26.56 | 8.12 |
EPS Diluted | 8.43 | 0.41 | -22.62 | -20.45 | -15.69 | -50.18 | -26.95 | -28.69 | -6.06 | -4.19 | 3.20 | -0.61 | -10.00 | 21.00 | -17.74 | -18.83 | -70.14 | 14.61 | -5.53 | 0.00 | 26.56 | 8.12 |
Weighted Avg Shares Out | 6.56M | 5.62M | 5.62M | 5.03M | 4.18M | 3.06M | 2.81M | 2.29M | 2.28M | 2.27M | 2.33M | 2.34M | 2.31M | 2.32M | 2.30M | 2.30M | 2.33M | 1.08M | 1.08M | 1.00M | 1.00M | 1.00M |
Weighted Avg Shares Out (Dil) | 6.56M | 5.62M | 5.62M | 5.03M | 4.18M | 3.06M | 2.81M | 2.29M | 2.28M | 2.27M | 2.33M | 2.34M | 2.31M | 2.33M | 2.30M | 2.30M | 2.33M | 1.12M | 1.12M | 1.00M | 1.00M | 1.00M |
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies
Origin Agritech Appoints Mr. Weibin Yan as Chief Executive Officer and Member of the Board of Directors; Dr. Gengchen Han to Remain as Chairman of the Board
Origin Agritech Appoints Patrick Cheng as Chief Financial Officer and Board Director
Origin Agritech Appoints Li Yang as Chief Operating Officer and Board Director
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
Origin Agritech Limited (SEED) Special Call Transcript
Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors
Origin Agritech to Hold Business Update Investor Webcast on Thursday, July 11 at 8 a.m. ET
Origin Agritech Announces Revolutionary Gene Editing Breakthrough, Featured in Top Science Journal Nature
Source: https://incomestatements.info
Category: Stock Reports